Genetic suppression of atrial fibrillation using a dominant-negative ether-a-go-go–related gene mutant
To access this article, please choose from the options below
This study was supported in part by grants from the Deutsche Forschungsgemeinschaft (BA 2084/3-2 to Dr. Bauer), from the University of Heidelberg and the Deutsche Forschungsgemeinschaft (FRONTIERS program to Dr. Thomas), from the ADUMED Foundation (to Dr. Thomas), and from the German Heart Foundation/German Foundation of Heart Research (to Dr. Thomas). Drs. Thomas, Kelemen, Voss, and Bauer received travel grants from St. Jude Medical. Drs. Thomas, Becker, and Bauer received lecture fees from St. Jude Medical.
Drs. Soucek and Thomas contributed equally to this work.
PII: S1547-5271(11)01045-9
doi:10.1016/j.hrthm.2011.09.008
© 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
